Giovanni Damiani to Angiogenesis Inhibitors
This is a "connection" page, showing publications Giovanni Damiani has written about Angiogenesis Inhibitors.
Connection Strength
0.041
-
Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021 02 05; 12(1):814.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.